본문으로 건너뛰기
cccskills
무료GitHub에 공개

es-cushing-evaluate-for-malignancy-high-ct-density-or-possible-carcinoma-adrenal-adenoma

This skill guides evaluation for malignancy using imaging in patients with a history of adrenal adenoma (post‑adrenalectomy Cushing’s syndrome) when the adenoma demonstrates a CT density of ≥10 Hounsfield units or when pathology is consistent with possible carcinoma. Trigger phrases include “CT density ≥10 HU”, “possible carcinoma on pathology”, and “post‑adrenalectomy CS patient with adrenal adenoma history”.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL

실행 점수 미검증

설치 방법 보기

포함된 파일(1)

  • SKILL.md3.0 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Evaluate for Malignancy Using Imaging in Adrenal Adenoma Patients With CT Density Greater Than or Equal to 10 Hounsfield Units or Pathology Consistent With Possible Carcinoma

STEP 1 — Gather Information

Collect history of adrenal adenoma (including prior pathology), confirm post‑adrenalectomy Cushing’s syndrome status, obtain latest non‑contrast adrenal CT Hounsfield unit measurement, and review any available pathology report for atypia or possible carcinoma.

STEP 2 — Rule In / Rule Out

If CT density ≥10 HU OR pathology report indicates possible carcinoma → proceed to imaging malignancy workup; otherwise → routine surveillance per follow‑up schedule (no malignancy‑focused imaging needed).

STEP 3 — Classify or Stratify

For positive triggers, classify lesion as indeterminate risk (CT density 10‑20 HU) or high suspicion (>20 HU, irregular margins, necrosis, or pathology suggestive of carcinoma) to guide intensity of imaging evaluation.

STEP 4 — Decide

If high‑suspicion features on dedicated adrenal protocol CT (washout <60%, size >4 cm, invasive growth) or MRI (chemical‑shift negative, irregular enhancement) → refer to endocrine oncology/surgical oncology for possible adrenalectomy, biopsy, or further staging; if indeterminate/low‑suspicion features → continue routine imaging surveillance every 6‑12 months.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on non‑contrast CT density; lipid‑poor adenomas can mimic malignancy and require washout or chemical‑shift MRI for clarification. Avoid percutaneous biopsy without correlative imaging features that suggest malignancy. Do not overlook subtle pathology atypia; when in doubt, pursue multidisciplinary review.

Concrete Clinical Example

A 48‑year‑old woman with prior left adrenalectomy for Cushing’s syndrome (benign adenoma) presents with a right adrenal nodule on non‑contrast CT measuring 13 HU. Pathology from the resected adenoma showed no atypia. The lesion undergoes adrenal protocol CT with washout of 38% (indeterminate). Subsequent MRI shows lipid‑poor adenoma (signal loss on opposed‑phase). Patient continues routine surveillance with imaging every 12 months.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

TODO: consider adding scripts/calc.py for the es-cushing-evaluate-for-malignancy-high-ct-density-or-possible-carcinoma-adrenal-adenoma calculator

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

780g-pump-adjustment

무료

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-acth-stim-test-interpretation

무료

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-adrenal-crisis-treatment

무료

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-ai-education

무료

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-lt4-monitoring

무료

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-cortisol-cutoff-ai-diagnosis

무료

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고